Commission Implementing Decision (EU) 2023/460 of 2 March 2023 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
235/2023 In force in the EEA
Yes Legal documents
Commission Implementing Decision (EU) 2023/460 of 2 March 2023 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Durchführungsbeschluss (EU) 2023/460 der Kommission vom 2. März 2023 zur Verschiebung des Ablaufdatums der Genehmigung von Imidacloprid zur Verwendung in Biozidprodukten der Produktart 18 gemäß der Verordnung (EU) Nr. 528/2012 des Europäischen Parlaments und des Rates
History
23.09.2023
Adopted JCD confirmed entry into force date
23.09.2023
Compliance date in the EEA
22.09.2023
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
14.06.2023
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
02.03.2023
Adoption date in the EU
23.03.2023
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.